News

Merck's Hypertension Drug Cuts Clinical Worsening Risk In Over 70% Of Patients On Double Background Therapy
Merck's Winrevair reduced clinical worsening in PAH patients in the Phase 3 HYPERION trial, building on prior positive study ...
iGaming Business4h
Weekend Report: ITIA suspends tennis players, new ICRG president, TaDa Gaming UK licence
The ITIA, International Centre for Responsible Gaming and TaDa Gaming feature in the Weekend Report. Welcome to the Weekend ...